NAMS MENOPAUSE CERTIFICATION EXAM
BANK MSCP (Menopause Society Certified Practitioner)
Exam Verified Real Exam Questions and Answers with
Detailed Rationales — 2026 Edition
About This Exam Bank
This comprehensive 300-question exam bank is designed to prepare healthcare
professionals for the Menopause Society Certified Practitioner (MSCP) examination,
administered by The Menopause Society (formerly NAMS). All questions are aligned with
the 2025/2026 Candidate Handbook and the five major content domains, which account
for 19% (Physiology), 20% (Symptoms), 21% (Health Disorders), 16% (Treatment),
and 19% (Preventive Care) of the exam.. Each question includes a detailed,
evidence-based Rationale to reinforce key concepts and support a guaranteed pass.
📋 PART 1: PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE MENOPAUSE
TRANSITION (Domain 1 ≈ 19% of exam)
1. What is the “climacteric phase”?
A) The final menstrual period
B) The period of endocrinologic, somatic, and transitory psychologic changes around the
time of menopause
C) The perimenopause only
D) The postmenopausal period
✅ Correct Answer: B
Rationale: The climacteric phase is the period of endocrinologic, somatic, and transitory
psychologic changes that occur around the time of menopause. It encompasses the
transition from the reproductive stage to the non-reproductive stage.
2. What is the definition of “early menopause”?
A) LMP before age 40
B) LMP before age 45
C) LMP before age 50
D) LMP after age 55
,✅ Correct Answer: B
Rationale: Early menopause is defined as the last menstrual period (LMP) occurring
before age 45. It should be distinguished from primary ovarian insufficiency, which occurs
before age 40.
3. What is the definition of “late menopause”?
A) LMP after age 50
B) LMP after age 54
C) LMP after age 55
D) LMP after age 60
✅ Correct Answer: B
Rationale: Late menopause is defined as an LMP after age 54.
4. What term describes menopause that occurs before age 40?
A) Early menopause
B) Premature ovarian insufficiency (POI)
C) Late menopause
D) Premenopause
✅ Correct Answer: B
Rationale: Primary ovarian insufficiency (POI) is defined as the loss of ovarian function
before the age of 40. It is distinguished from early menopause, which occurs between
ages 40 and 45.
5. According to the STRAW+10 staging system, what characterizes “early menopause
transition” (stage –2)?
A) 60 or more consecutive days of amenorrhea
B) Persistent difference of 7 days or more in the length of consecutive cycles
C) Heavy menstrual bleeding
D) Regular cycles 26–35 days
✅ Correct Answer: B
Rationale: Stage –2 (early menopause transition) is marked by persistent difference of ≥ 7
days in the length of consecutive cycles and is when cycle irregularity begins.
6. What does the luteal out-of-phase (LOOP) event explain?
A) Elevated FSH in early menopause
B) Elevated estrogen levels in perimenopausal women
C) Low progesterone in perimenopause
D) Androgen excess in menopause
,✅ Correct Answer: B
Rationale: The LOOP event explains why some perimenopausal women have elevated
estrogen levels occasionally. Elevated FSH recruits a second follicle, causing a
follicular-phase-like rise in estradiol superimposed on the mid-to-late luteal phase of the
ovulatory cycle.
7. In which post-menopausal stage do vasomotor symptoms (VMS) predominate?
A) Stage +1a, +1b, +1c (early postmenopause)
B) Stage +2 (late postmenopause)
C) Menopause transition
D) Late reproductive years
✅ Correct Answer: A
Rationale: In early postmenopause (stage +1a, +1b, +1c) , which is the first 2 years after the
final menstrual period (FMP), FSH rises, estradiol decreases, and VMS predominate. Later
stages are dominated by urogenital and somatic aging.
8. What are the typical endocrine laboratory findings after menopause?
A) Low FSH, low LH, high estradiol
B) Elevated FSH and LH, low estradiol
C) Low FSH, high LH, high progesterone
D) Normal FSH, low estradiol
✅ Correct Answer: B
Rationale: After menopause, the ovaries no longer produce significant estrogen, leading
to loss of negative feedback and elevated FSH and LH. Low estradiol is the expected
finding.
9. Which laboratory marker is considered a superior marker of menopause?
A) FSH
B) LH
C) AMH (anti-Müllerian hormone)
D) Inhibin B
✅ Correct Answer: C
Rationale: AMH (anti-Müllerian hormone) is a superior marker for menopause. It is
produced by the ovarian follicle pool and declines as follicles are depleted, making it a
better reflection of ovarian reserve. FSH can be variable in perimenopause.
10. Where are estrogen receptors located? (Select all that apply)
A) Vagina
B) Vulva
, C) Urethra
D) Trigone of the bladder
✅ Correct Answer: A, B, C, D
Rationale: Estrogen receptors are abundant throughout the lower urinary and genital
tracts, including the vagina, vulva, urethra, and trigone of the bladder. This explains why
estrogen therapy is effective for genitourinary syndrome of menopause (GSM).
11. What are the vaginal changes associated with menopause?
A) Thickening of the vaginal epithelium
B) Thinning, loss of elasticity, and loss or absence of rugae
C) Increased rugae and increased elasticity
D) No change
✅ Correct Answer: B
Rationale: Menopause leads to thinning of the vaginal epithelium, loss of elasticity, and
loss or absence of rugae due to estrogen deficiency. These changes contribute to GSM
symptoms such as dyspareunia, dryness, and irritation.
12. How does menopause alter the anatomy of the vagina and urethra?
A) The vagina widens, and the urethra moves away from the introitus
B) The vagina narrows, and the urethra moves closer to the introitus
C) The vagina lengthens, and the urethra shortens
D) No anatomic changes occur
✅ Correct Answer: B
Rationale: Estrogen deficiency during menopause causes narrowing of the vagina and a
shortening of the urethra, which can move closer to the introitus. These changes increase
the risk of stress urinary incontinence and recurrent urinary tract infections.
13. How do estradiol levels differ between obese and normal-weight women during
menopause?
A) Obese women have lower estradiol levels throughout
B) Obese women have lower premenopause yet higher postmenopause estradiol levels
C) Obese women have higher estradiol levels throughout
D) No difference exists
✅ Correct Answer: B
Rationale: Obese women are more likely to have lower premenopause yet higher
postmenopause estradiol levels compared with women of normal weight. This is because
peripheral conversion of androgens to estrogen in adipose tissue continues even after
ovarian production ends, potentially increasing the risk of endometrial cancer.
BANK MSCP (Menopause Society Certified Practitioner)
Exam Verified Real Exam Questions and Answers with
Detailed Rationales — 2026 Edition
About This Exam Bank
This comprehensive 300-question exam bank is designed to prepare healthcare
professionals for the Menopause Society Certified Practitioner (MSCP) examination,
administered by The Menopause Society (formerly NAMS). All questions are aligned with
the 2025/2026 Candidate Handbook and the five major content domains, which account
for 19% (Physiology), 20% (Symptoms), 21% (Health Disorders), 16% (Treatment),
and 19% (Preventive Care) of the exam.. Each question includes a detailed,
evidence-based Rationale to reinforce key concepts and support a guaranteed pass.
📋 PART 1: PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE MENOPAUSE
TRANSITION (Domain 1 ≈ 19% of exam)
1. What is the “climacteric phase”?
A) The final menstrual period
B) The period of endocrinologic, somatic, and transitory psychologic changes around the
time of menopause
C) The perimenopause only
D) The postmenopausal period
✅ Correct Answer: B
Rationale: The climacteric phase is the period of endocrinologic, somatic, and transitory
psychologic changes that occur around the time of menopause. It encompasses the
transition from the reproductive stage to the non-reproductive stage.
2. What is the definition of “early menopause”?
A) LMP before age 40
B) LMP before age 45
C) LMP before age 50
D) LMP after age 55
,✅ Correct Answer: B
Rationale: Early menopause is defined as the last menstrual period (LMP) occurring
before age 45. It should be distinguished from primary ovarian insufficiency, which occurs
before age 40.
3. What is the definition of “late menopause”?
A) LMP after age 50
B) LMP after age 54
C) LMP after age 55
D) LMP after age 60
✅ Correct Answer: B
Rationale: Late menopause is defined as an LMP after age 54.
4. What term describes menopause that occurs before age 40?
A) Early menopause
B) Premature ovarian insufficiency (POI)
C) Late menopause
D) Premenopause
✅ Correct Answer: B
Rationale: Primary ovarian insufficiency (POI) is defined as the loss of ovarian function
before the age of 40. It is distinguished from early menopause, which occurs between
ages 40 and 45.
5. According to the STRAW+10 staging system, what characterizes “early menopause
transition” (stage –2)?
A) 60 or more consecutive days of amenorrhea
B) Persistent difference of 7 days or more in the length of consecutive cycles
C) Heavy menstrual bleeding
D) Regular cycles 26–35 days
✅ Correct Answer: B
Rationale: Stage –2 (early menopause transition) is marked by persistent difference of ≥ 7
days in the length of consecutive cycles and is when cycle irregularity begins.
6. What does the luteal out-of-phase (LOOP) event explain?
A) Elevated FSH in early menopause
B) Elevated estrogen levels in perimenopausal women
C) Low progesterone in perimenopause
D) Androgen excess in menopause
,✅ Correct Answer: B
Rationale: The LOOP event explains why some perimenopausal women have elevated
estrogen levels occasionally. Elevated FSH recruits a second follicle, causing a
follicular-phase-like rise in estradiol superimposed on the mid-to-late luteal phase of the
ovulatory cycle.
7. In which post-menopausal stage do vasomotor symptoms (VMS) predominate?
A) Stage +1a, +1b, +1c (early postmenopause)
B) Stage +2 (late postmenopause)
C) Menopause transition
D) Late reproductive years
✅ Correct Answer: A
Rationale: In early postmenopause (stage +1a, +1b, +1c) , which is the first 2 years after the
final menstrual period (FMP), FSH rises, estradiol decreases, and VMS predominate. Later
stages are dominated by urogenital and somatic aging.
8. What are the typical endocrine laboratory findings after menopause?
A) Low FSH, low LH, high estradiol
B) Elevated FSH and LH, low estradiol
C) Low FSH, high LH, high progesterone
D) Normal FSH, low estradiol
✅ Correct Answer: B
Rationale: After menopause, the ovaries no longer produce significant estrogen, leading
to loss of negative feedback and elevated FSH and LH. Low estradiol is the expected
finding.
9. Which laboratory marker is considered a superior marker of menopause?
A) FSH
B) LH
C) AMH (anti-Müllerian hormone)
D) Inhibin B
✅ Correct Answer: C
Rationale: AMH (anti-Müllerian hormone) is a superior marker for menopause. It is
produced by the ovarian follicle pool and declines as follicles are depleted, making it a
better reflection of ovarian reserve. FSH can be variable in perimenopause.
10. Where are estrogen receptors located? (Select all that apply)
A) Vagina
B) Vulva
, C) Urethra
D) Trigone of the bladder
✅ Correct Answer: A, B, C, D
Rationale: Estrogen receptors are abundant throughout the lower urinary and genital
tracts, including the vagina, vulva, urethra, and trigone of the bladder. This explains why
estrogen therapy is effective for genitourinary syndrome of menopause (GSM).
11. What are the vaginal changes associated with menopause?
A) Thickening of the vaginal epithelium
B) Thinning, loss of elasticity, and loss or absence of rugae
C) Increased rugae and increased elasticity
D) No change
✅ Correct Answer: B
Rationale: Menopause leads to thinning of the vaginal epithelium, loss of elasticity, and
loss or absence of rugae due to estrogen deficiency. These changes contribute to GSM
symptoms such as dyspareunia, dryness, and irritation.
12. How does menopause alter the anatomy of the vagina and urethra?
A) The vagina widens, and the urethra moves away from the introitus
B) The vagina narrows, and the urethra moves closer to the introitus
C) The vagina lengthens, and the urethra shortens
D) No anatomic changes occur
✅ Correct Answer: B
Rationale: Estrogen deficiency during menopause causes narrowing of the vagina and a
shortening of the urethra, which can move closer to the introitus. These changes increase
the risk of stress urinary incontinence and recurrent urinary tract infections.
13. How do estradiol levels differ between obese and normal-weight women during
menopause?
A) Obese women have lower estradiol levels throughout
B) Obese women have lower premenopause yet higher postmenopause estradiol levels
C) Obese women have higher estradiol levels throughout
D) No difference exists
✅ Correct Answer: B
Rationale: Obese women are more likely to have lower premenopause yet higher
postmenopause estradiol levels compared with women of normal weight. This is because
peripheral conversion of androgens to estrogen in adipose tissue continues even after
ovarian production ends, potentially increasing the risk of endometrial cancer.
